IB

International BM Biomedicine Holdings AG

Europe, Basel-Stadt, Switzerland, Basel

Description

International BM Biomedicine Holdings AG invests in biopharmaceutical companies located in the United States.

Investor Profile

International BM Biomedicine Holdings AG has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Innovation Management
  • Medical
  • Professional Services
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does International BM Biomedicine Holdings AG frequently co-invest with?

DeNovo Ventures
North America, California, United States, Saratoga
Co-Investments: 1
Duke University
North America, North Carolina, United States, Durham
Co-Investments: 1
Sevin Rosen Funds
North America, Texas, United States, Dallas
Co-Investments: 1
Mayfield Fund
North America, California, United States, Menlo Park
Co-Investments: 1
Bosch Capital
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 1
NM
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
BioVeda Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 1
Vulcan
North America, Washington, United States, Seattle
Co-Investments: 1
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 1

What are some of recent deals done by International BM Biomedicine Holdings AG?

Renovis

South San Francisco, California, United States

Renovis,is a biopharmaceutical company developing drugs to treat neurological diseases and disorders.

Innovation ManagementMedicalProfessional Services
Series BJan 10, 2002
Amount Raised: $34,300,000
Cytokinetics

South San Francisco, California, United States

Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.

BiopharmaBiotechnologyHealth Care
Series BOct 12, 1999
Amount Raised: $20,000,000

Find More Investors Like International BM Biomedicine Holdings AG

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

International BM Biomedicine Holdings AG | Pipeseed